Treatments applied in patients with covid-19 infection with type 2 diabetes mellitus

Abstract

Introduction. Coronaviruses are RNA viruses that cause diverse types of respiratory illnesses. At the end of 2019, a new coronavirus was identified and declared a pandemic on March 11, 2020. There is the development of diabetes in patients with SARS-CoV-2, so it is possible that it could cause alterations in glucose metabolism leading to the development of diabetes mellitus. Objective. To conduct a bibliographic review of the treatments applied in patients infected with Covid-19 and who have type 2 diabetes mellitus as their underlying pathology. Methodology. Databases such as PubMed, Scopus, Springer, Elsevier were used and included articles in Spanish and English published within the period from 2019 to 2023. Results. All the articles analyzed describe the use of metformin, insulin, and corticosteroids as the mainstay of treatment, accompanied by patient education and communication between health personnel and the patient. Conclusion. Treatment is based on the patient's usual medication, but with slight adjustments depending on glucose control. Different treatments have also been described such as incretins, ACE inhibitors, chloroquine, and hydroxychloroquine and SGLT2 inhibitors among others that have acted in diverse ways to control this pathology.